Investment Newsletters

CAPR

H.C. Wainwright Reiterates Buy On Capricor As It Plans To Pursue A Cenderitide Clinical Program

In a research note issued to investors today, analyst Reni Benjamin of H.C.

Ben Mahaney, Editor — October 13, 2014, 3:53 PM EDT

Capricor Represents An Undervalued Player With Significant Upside, Says H.C. Wainwright

In a research report issued today, H.C.

Corey Williams — October 7, 2014, 4:54 PM EDT

« 1 2